http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160140567-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
filingDate 2016-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cf9a4f0086aa1acc86fd0ce677587e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7997126de7f7e531e4bb5a8f94f1d3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d880b98460d61bc709f62768aed070
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1283502d23a0c6bdc12595993a9a70d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17a13e8d138e16c7d0b3da6595f7e375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102f323829ea35e610998ca58d10f686
publicationDate 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20160140567-A
titleOfInvention Pharmaceutical composition comprising oseltamivir free base
abstract The present invention provides a pharmaceutical composition for oral administration containing oseltamivir free base, preferably oseltamivir free base wherein 90% of the particles have a particle size of 200 mu m or less, a pharmaceutical product containing the same, and a preparation method thereof do. The pharmaceutical compositions of the present invention may be in the form of capsules, tablets, dry syrups, chewable tablets or powders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180101158-A
priorityDate 2016-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012093738-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857644
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452841941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160967529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451747373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917

Total number of triples: 46.